IGF‑1 LR3 is a modified insulin‑like growth factor‑1 analog commonly used in receptor binding and signaling studies, engineered to extend stability and reduce binding to IGF binding proteins. Supplied as a lyophilized powder for in‑vitro research into IGF‑1 receptor pathways and downstream signaling.
WARNING & DISCLAIMER: This product is intended strictly for laboratory research use only. It is not a drug, food, or cosmetic and should not be used on or by humans or animals. The buyer acknowledges and warrants that they possess the necessary qualifications, licenses, and equipment to handle this material safely and in compliance with all applicable laws. Improper handling, including but not limited to reconstitution, injection, or any form of consumption, is strictly prohibited and done at the buyer's own risk. We assume no liability for misuse of this product.